Finance

Beta
Lists
INTS:NASDAQ
Intensity Therapeutics Inc
$4.15
+1.22%
(+0.050) 1D
Jul 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTS...
Open
$4.15
High
$4.20
Low
$4.13
Mkt. cap
11.22M
Avg. vol.
45.91K
Volume
59.76K
52-wk high
$43.50
52-wk low
$3.51
EPS
-$7.18
Shares outstanding
2.70M
No. of employees
5
Open
$4.15
High
$4.20
Low
$4.13
Mkt. cap
11.22M
Avg. vol.
45.91K
Volume
59.76K
52-wk high
$43.50
52-wk low
$3.51
EPS
-$7.18
Shares outstanding
2.70M
No. of employees
5
News stories
From sources across the web
About Intensity Therapeutics Inc
CEO-
Employees5
Founded2012
HeadquartersShelton, Connecticut, United States
SectorBiotechnology
Websiteintensitytherapeutics.com
Analyst ratings
Based on 1 analyst giving stock ratings to INTS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INTS in the last 3 months
Highest
Current $4.15
$30.00 (+622.89%)
Average
$30.00 (+622.89%)
Lowest
$30.00 (+622.89%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Molloy
Alliance Global Partners
Buy
Reiterated
$30.00
+622.9%
05/08/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Upgraded
$20.00
+381.9%
03/30/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$30.00
+622.9%
03/30/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$125.00
+2,912%
11/12/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.54M
1.55M
1.50M
1.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.16M
1.18M
1.64M
1.33M
Operating expense
2.70M
2.73M
3.14M
2.53M
Total operating expenses
2.70M
2.73M
3.14M
2.53M
Operating income
-2.70M
-2.73M
-3.14M
-2.53M
Other non operating income
151.00K
3.00K
1.00K
-2.00K
EBT including unusual items
-2.54M
-2.67M
-3.05M
-2.43M
EBT excluding unusual items
-2.54M
-2.67M
-3.05M
-2.43M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.54M
-2.67M
-3.05M
-2.43M
Net profit margin
-
-
-
-
Earnings per share
-3.25
-1.50
-
-0.96
Interest and investment income
17.00K
59.00K
88.00K
94.00K
Interest expense
-
-
-
-
Net interest expenses
17.00K
59.00K
88.00K
94.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer